<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-07T08:03:27Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/8040" metadataPrefix="oai_dc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/8040</identifier><datestamp>2026-02-03T12:10:58Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37959</setSpec></header><metadata><oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>AD0157, a pyrrolidinedione fungal metabolite, inhibits angiogenesis by targeting the Akt signaling pathway</dc:title>
   <dc:creator>García-Caballero, Melissa</dc:creator>
   <dc:creator>Cañedo, Librada</dc:creator>
   <dc:creator>Fernández-Medarde, Antonio</dc:creator>
   <dc:creator>Rodríguez-Quesada, Ana María</dc:creator>
   <dc:creator>Medina-Torres, Miguel Ángel</dc:creator>
   <dc:subject>Neovascularización</dc:subject>
   <dc:subject>Angiogenesis</dc:subject>
   <dc:subject>Akt signaling</dc:subject>
   <dc:subject>Apoptosis</dc:subject>
   <dc:subject>Natural products</dc:subject>
   <dc:description>In the course of a screening program for the inhibitors of angiogenesis from marine&#xd;
sources, AD0157, a pyrrolidinedione fungal metabolite, was selected for its&#xd;
angiosupressive properties. AD0157 inhibited the growth of endothelial and tumor cells in&#xd;
culture in the micromolar range. Our results show that subtoxic doses of this compound&#xd;
inhibit certain functions of endothelial cells, namely, differentiation, migration and&#xd;
proteolytic capability. Inhibition of the mentioned essential steps of in vitro angiogenesis is&#xd;
in agreement with the observed antiangiogenic activity, substantiated by using two in vivo&#xd;
angiogenesis models, the chorioallantoic membrane and the zebrafish embryo&#xd;
neovascularization assays, and by the ex vivo mouse aortic ring assay. Our data indicate&#xd;
that AD0157 induces apoptosis in endothelial cells through chromatin condensation, DNA&#xd;
fragmentation, increases in the subG1 peak and caspase activation. The data shown here&#xd;
altogether indicate for the first time that AD0157 displays antiangiogenic effects, both in&#xd;
vitro and in vivo, that are exerted partly by targeting the Akt signaling pathway in activated&#xd;
endothelial cells. The fact that these effects are carried out at lower concentrations than&#xd;
those required for other inhibitors of angiogenesis makes AD0157 a new promising drug&#xd;
candidate for further evaluation in the treatment of cancer and other angiogenesis-related&#xd;
pathologies. [Our experimental work is supported by grant P12-CTS-1507 (Andalusian&#xd;
Government and FEDER) and funds from group BIO-267 (Andalusian Government). The&#xd;
"CIBER de Enfermedades Raras" is an initiative from the ISCIII (Spain). This&#xd;
communication has the support of a travel grant "Universidad de Málaga. Campus de&#xd;
Excelencia Internacional Andalucía Tech"].</dc:description>
   <dc:description>Universidad de Málaga. Campus de Excelencia Internacional Andalucía Tech</dc:description>
   <dc:date>2014-09-16T09:50:58Z</dc:date>
   <dc:date>2014-09-16T09:50:58Z</dc:date>
   <dc:date>2014-09-11</dc:date>
   <dc:date>2014-09-16</dc:date>
   <dc:type>conference output</dc:type>
   <dc:identifier>http://hdl.handle.net/10630/8040</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>XXXVII Congreso SEBBM</dc:relation>
   <dc:relation>Granada, España</dc:relation>
   <dc:relation>Del 9 al 12 de Septiembre de 2014</dc:relation>
   <dc:rights>open access</dc:rights>
   <dc:format>application/pdf</dc:format>
</oai_dc:dc>
</metadata></record></GetRecord></OAI-PMH>